Experiences from daily practice of upadacitinib treatment on atopic dermatitis with a focus on hand eczema: Results from the BioDay registry

Overview of attention for article published in Contact Dermatitis (01051873), January 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news: 2 news outlets

twitter: 1 X user

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 21 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Upadacitinib Linked with Improvement for Hand Eczema in Patients with Atopic Dermatitis

Practical Dermatology, 02 Jan 2024

The new observational analysis looked at a variety of outcome measures. Results from a new study suggest that upadacitinib is…

Upadacitinib Effective on for Atopic Dermatitis Patients with Concomitant Hand Eczema

HCP Live, 23 Jan 2023

Upadacitinib was found to be effective following 16 weeks of treatment for atopic dermatitis (AD) patients with concomitant…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.